{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T03:22:28Z","timestamp":1781148148072,"version":"3.54.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P01 149630"],"award-info":[{"award-number":["P01 149630"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P01 149630"],"award-info":[{"award-number":["P01 149630"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>A low respiratory arousal threshold is a key endotype responsible for obstructive sleep apnea (OSA) pathogenesis. Pimavanserin is an antiserotoninergic capable of suppressing CO2-mediated arousals without affecting the respiratory motor response in animal models, and thus it holds potential for increasing the arousal threshold in OSA and subsequently reducing OSA severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We measured the effect of pimavanserin on arousal threshold (primary outcome), OSA severity, arousal index, and other OSA endotypes (secondary outcomes).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 18 OSA participants were studied in a randomized, double-blind, crossover study. Patients received a single dose of placebo or pimavanserin 34 mg 4 hours before in-lab polysomnography. Airflow was measured with an oronasal mask attached to a pneumotachograph, and ventilatory drive was recorded with an intraesophageal electromyography catheter. Results are presented as mean or median changes (\u0394) and 95% confidence intervals (CIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Pimavanserin did not increase the arousal threshold, nor did it decrease OSA severity or arousal index. It, however, prolonged total sleep time (\u0394[confidence interval (CI)], 39.5 [95%CI, \u22121.2 to 80.1] min). In an exploratory analysis, a subgroup of seven patients who had a 10% or more increase in arousal threshold on pimavanserin exhibited a decrease in AHI4 (hypopneas associated with 4% desaturation) (\u0394[CI], 5.6 [95%CI, 3.6\u201311.1] events\/h) and hypoxic burden (\u0394[CI], 22.3 [95%CI, 6.6\u201332.3] %min\/h).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A single dose of pimavanserin did not have a significant effect on arousal threshold or OSA severity. However, in a post hoc analysis, a subset of patients who exhibited an increase in arousal threshold on pimavanserin showed a small decrease in OSA severity. Thus, if the arousal threshold could be increased with pimavanserin, perhaps with longer dosing to reach higher drug blood concentrations, then the desired effect on OSA severity might be achievable.<\/jats:p>\n                    <jats:p>Clinical trial registered with ClinicalTrials.gov (NCT04538755).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202205-419oc","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T16:31:56Z","timestamp":1660149116000},"page":"2062-2069","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":16,"title":["Effect of Pimavanserin on the Respiratory Arousal Threshold from Sleep: A Randomized Trial"],"prefix":"10.1093","volume":"19","author":[{"given":"Ludovico","family":"Messineo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Calianese","sequence":"additional","affiliation":[{"name":"Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham & Women\u2019s Hospital & Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8520-8860","authenticated-orcid":false,"given":"Tamar","family":"Sofer","sequence":"additional","affiliation":[{"name":"Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham & Women\u2019s Hospital & Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Vena","sequence":"additional","affiliation":[{"name":"Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham & Women\u2019s Hospital & Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Azarbarzin","sequence":"additional","affiliation":[{"name":"Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham & Women\u2019s Hospital & Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Labarca","sequence":"additional","affiliation":[{"name":"Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham & Women\u2019s Hospital & Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Taranto-Montemurro","sequence":"additional","affiliation":[{"name":"Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham & Women\u2019s Hospital & Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Chae","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham & Women\u2019s Hospital & Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham & Women\u2019s Hospital & Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham & Women\u2019s Hospital & Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Smith","sequence":"additional","affiliation":[{"name":"Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham & Women\u2019s Hospital & Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"White","sequence":"additional","affiliation":[{"name":"Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham & Women\u2019s Hospital & Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Sands","sequence":"additional","affiliation":[{"name":"Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham & Women\u2019s Hospital & Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wellman","sequence":"additional","affiliation":[{"name":"Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham & Women\u2019s Hospital & Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"2026012203353670400_bib1","first-page":"807","article-title":"Arousal: the forgotten response to respiratory stimuli","volume":"118","author":"Phillipson","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"2026012203353670400_bib2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1164\/rccm.200307-1023OC","article-title":"Role of arousals in the pathogenesis of obstructive sleep apnea","volume":"169","author":"Younes","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203353670400_bib3","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/japplphysiol.00972.2010","article-title":"A method for measuring and modeling the physiological traits causing obstructive sleep apnea","volume":"110","author":"Wellman","year":"2011","journal-title":"J Appl Physiol (1985)."},{"key":"2026012203353670400_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5665\/sleep.2390","article-title":"Acetazolamide attenuates the ventilatory response to arousal in patients with obstructive sleep apnea","volume":"36","author":"Edwards","year":"2013","journal-title":"Sleep (Basel)"},{"key":"2026012203353670400_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/thx.2008.112953","article-title":"Upper airway function and arousability to ventilatory challenge in slow wave versus stage 2 sleep in obstructive sleep apnoea","volume":"65","author":"Ratnavadivel","year":"2010","journal-title":"Thorax"},{"key":"2026012203353670400_bib6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1152\/jn.00213.2015","article-title":"5-HT2A receptor activation is necessary for CO2-induced arousal","volume":"114","author":"Buchanan","year":"2015","journal-title":"J Neurophysiol"},{"key":"2026012203353670400_bib7","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1523\/JNEUROSCI.2182-17.2018","article-title":"Dorsal raphe serotonin neurons mediate CO2-induced arousal from sleep","volume":"38","author":"Smith","year":"2018","journal-title":"J Neurosci"},{"key":"2026012203353670400_bib8","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/resp.14110","article-title":"Addition of zolpidem to combination therapy with atomoxetine-oxybutynin increases sleep efficiency and the respiratory arousal threshold in obstructive sleep apnoea: a randomized trial","volume":"26","author":"Messineo","year":"2021","journal-title":"Respirology"},{"key":"2026012203353670400_bib9","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner J"},{"key":"2026012203353670400_bib10","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1164\/rccm.201808-1493OC","article-title":"The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. A randomized, placebo-controlled, double-blind crossover trial","volume":"199","author":"Taranto-Montemurro","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203353670400_bib11","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1164\/rccm.200605-597OC","article-title":"Endogenous excitatory drive modulating respiratory muscle activity across sleep-wake states","volume":"174","author":"Chan","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203353670400_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1164\/rccm.201209-1654OC","article-title":"Identification of the mechanism mediating genioglossus muscle suppression in REM sleep","volume":"187","author":"Grace","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203353670400_bib13","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.chest.2020.01.012","article-title":"Effects of the combination of atomoxetine and oxybutynin on OSA endotypic traits","volume":"157","author":"Taranto-Montemurro","year":"2020","journal-title":"Chest"},{"key":"2026012203353670400_bib14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.5664\/jcsm.6576","article-title":"AASM scoring manual updates for 2017 (version 2.4)","volume":"13","author":"Berry","year":"2017","journal-title":"J Clin Sleep Med"},{"key":"2026012203353670400_bib15","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/eurheartj\/ehy624","article-title":"The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the osteoporotic fractures in men study and the sleep heart health study","volume":"40","author":"Azarbarzin","year":"2019","journal-title":"Eur Heart J"},{"key":"2026012203353670400_bib16","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/thoraxjnl-2021-217756","article-title":"Neural ventilatory drive decline as a predominant mechanism of obstructive sleep apnoea events","volume":"77","author":"Gell","year":"2022","journal-title":"Thorax"},{"key":"2026012203353670400_bib17","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1164\/rccm.201707-1435OC","article-title":"Phenotyping pharyngeal pathophysiology using polysomnography in patients with obstructive sleep apnea","volume":"197","author":"Sands","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203353670400_bib18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1183\/09031936.00062914","article-title":"Quantifying the ventilatory control contribution to sleep apnoea using polysomnography","volume":"45","author":"Terrill","year":"2015","journal-title":"Eur Respir J"},{"key":"2026012203353670400_bib19","first-page":"961","article-title":"an integrative model of physiological traits can be used to predict obstructive sleep apnea and response to non positive airway pressure therapy","volume":"38","author":"Owens","year":"2015","journal-title":"Sleep (Basel)"},{"key":"2026012203353670400_bib20","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.5665\/sleep.6226","article-title":"The combination of supplemental oxygen and a hypnotic markedly improves obstructive sleep apnea in patients with a mild to moderate upper airway collapsibility","volume":"39","author":"Edwards","year":"2016","journal-title":"Sleep (Basel)"},{"key":"2026012203353670400_bib21","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1113\/jphysiol.2011.223925","article-title":"Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea","volume":"590","author":"Edwards","year":"2012","journal-title":"J Physiol"},{"key":"2026012203353670400_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.chest.2021.08.080","article-title":"Reboxetine plus oxybutynin for OSA treatment: a 1-week, randomized, placebo-controlled, double-blind crossover trial","volume":"161","author":"Perger","year":"2022","journal-title":"Chest"},{"key":"2026012203353670400_bib23","first-page":"368","article-title":"Pimavanserin (Nuplazid): a treatment for hallucinations and delusions associated with Parkinson\u2019s disease","volume":"42","author":"Cruz","year":"2017","journal-title":"P&T"},{"key":"2026012203353670400_bib24","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1113\/JP280173","article-title":"Zolpidem increases sleep efficiency and the respiratory arousal threshold without changing sleep apnoea severity and pharyngeal muscle activity","volume":"598","author":"Messineo","year":"2020","journal-title":"J Physiol"},{"key":"2026012203353670400_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fphar.2020.00087","article-title":"Pimavanserin: a novel antipsychotic with potentials to address an unmet need of older adults with dementia-related psychosis","volume":"11","author":"Yunusa","year":"2020","journal-title":"Front Pharmacol"},{"key":"2026012203353670400_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1081\/DMR-120023681","article-title":"PM frequencies of major CYPs in Asians and Caucasians","volume":"35","author":"Mizutani","year":"2003","journal-title":"Drug Metab Rev"},{"key":"2026012203353670400_bib27","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/cpt.690","article-title":"Worldwide distribution of cytochrome p450 alleles: a meta-analysis of population-scale sequencing projects","volume":"102","author":"Zhou","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"2026012203353670400_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1164\/rccm.202101-0237OC","article-title":"Ventilatory drive withdrawal rather than reduced genioglossus compensation as a mechanism of obstructive sleep apnea in REM sleep","volume":"205","author":"Messineo","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203353670400_bib29","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1164\/ajrccm.160.5.9812007","article-title":"The effects of trazodone with L-tryptophan on sleep-disordered breathing in the English bulldog","volume":"160","author":"Veasey","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203353670400_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.chest.2019.09.002","article-title":"Phenotypic subtypes of OSA: a challenge and opportunity for precision medicine","volume":"157","author":"Zinchuk","year":"2020","journal-title":"Chest"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/19\/12\/2062\/66328597\/annalsats_19_12_2062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/19\/12\/2062\/66328597\/annalsats_19_12_2062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:39:09Z","timestamp":1769071149000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/19\/12\/2062\/8417763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12,1]]},"published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202205-419oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12]]},"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"2022-05-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}